Cargando…
Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors
Galantamine (GAL) and curcumin (CU) are alkaloids used to improve symptomatically neurodegenerative conditions like Alzheimer’s disease (AD). GAL acts mainly as an inhibitor of the enzyme acetylcholinesterase (AChE). CU binds to amyloid-beta (Aβ) oligomers and inhibits the formation of Aβ plaques. H...
Autores principales: | Stavrakov, Georgi, Philipova, Irena, Lukarski, Atanas, Atanasova, Mariyana, Zheleva, Dimitrina, Zhivkova, Zvetanka D., Ivanov, Stefan, Atanasova, Teodora, Konstantinov, Spiro, Doytchinova, Irini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435983/ https://www.ncbi.nlm.nih.gov/pubmed/32717861 http://dx.doi.org/10.3390/molecules25153341 |
Ejemplares similares
-
Novel hits for acetylcholinesterase inhibition derived by docking-based screening on ZINC database
por: Doytchinova, Irini, et al.
Publicado: (2018) -
Discovery of a Novel Acetylcholinesterase Inhibitor by Fragment-Based Design and Virtual Screening
por: Stavrakov, Georgi, et al.
Publicado: (2021) -
A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders
por: Simeonova, Rumyana, et al.
Publicado: (2021) -
Ex Vivo Antioxidant and Cholinesterase Inhibiting Effects of a Novel Galantamine–Curcumin Hybrid on Scopolamine-Induced Neurotoxicity in Mice
por: Simeonova, Rumyana, et al.
Publicado: (2022) -
A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells
por: Mladenova, Kirilka, et al.
Publicado: (2021)